That point is a very important one when discussing the results, Vince explains that the problem is in the vehicle arm for the inflammatory lesions only @18.30 circa in the interview - that's where the alcohol from Permetrex has effect and not in the deeper dermis layer where the non-inflammatory lesions are and where statistical significance (separation from Permetrex) was achieved.
https://omny.fm/shows/ceo-interviews/vince-ippolito-botanix-pharmaceuticals
(thanks to juztech)
What's the vehicle anyhow?, page-92
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.5¢ |
Change
-0.015(3.95%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 37.5¢ | 35.0¢ | $1.972M | 5.430M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 229793 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 227296 | 5 |
View Market Depth
| Last trade - 10.37am 15/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |